Table 1.
Baseline characteristics of the previously untreated CD20-positive DLBCL or FL patients receiving first-line R-chemo treatment
| Variables | FL (n = 29) | DLBCL (n = 258) |
|---|---|---|
| Male | 10 (34.5) | 148 (57.4) |
| Age (years) | 53.3 (29.3–79.6) | 57.2 (12.8–88.4) |
| ≤60 years | 21 (72.4) | 154 (59.7) |
| 61–80 years | 8 (27.6) | 98 (38.0) |
| >80 years | 0 | 6 (2.3) |
| Stage | ||
| I | 0 | 38 (14.8) |
| II | 4 (13.8) | 86 (33.5) |
| III | 16 (55.2) | 66 (25.6) |
| IV | 9 (31.0) | 67 (26.1) |
| ECOG | ||
| 0 | 3 (10.3) | 68 (26.4) |
| 1 | 24 (82.8) | 167 (64.7) |
| 2 | 2 (6.9) | 17 (6.6) |
| 3 | 0 | 6 (2.3) |
| 4 | 0 | 0 |
| IPI | ||
| Low risk | – | 131 (51.2) |
| Low-intermediate risk | – | 66 (25.8) |
| Intermediate-high risk | – | 43 (16.8) |
| High risk | – | 16 (6.3) |
| FLIPI | ||
| Low risk | 9 (31.0) | – |
| Intermediate risk | 11 (37.9) | – |
| High risk | 9 (31.0) | – |
| Bulky disease* | 14 (48.3) | 80 (31.0) |
| Extranodal sites ≥1 | 24 (82.8) | 151 (58.5) |
Data were shown as n (%) or median (range). –: Not applicable; ECOG: Eastern cooperative oncology group performance status; IPI: International prognostic index; FLIPI: Follicular lymphoma international prognostic index; FL: Follicular lymphoma; DLBCL: Diffuse large B-cell lymphoma. Bulky disease*: Tumor maximum diameter ≥7.5 cm.